INVO pro forma shows $6.2M revenue and $9.2M net loss for combined WFI acquisition in FY2022

INVO Fertility, Inc.

Combined pro forma revenue for FY2022: $6.20M ($822k INVO + $5.38M WFI); net loss of $9.21M vs INVO standalone loss of $10.89M.
Total purchase consideration of $10M, with $2.5M upfront and $7.5M payable over three years; sellers may take stock at set prices.
Preliminary goodwill of $10.06M recorded; purchase price allocation subject to final valuation within 12 months.
Pro forma for Q1 2023: combined revenue $1.69M, net loss $2.09M; compared to INVO standalone revenue $0.35M and loss $2.55M.
WFI (WFRSA + FLOW) had audited FY2022 revenue of $5.38M and net income of $1.68M on a standalone basis.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Asset Purchase Agreement with WFRSA and The Elizabeth Pritts Revocable Living Trust (effective 2023-03-16).

Action: entry
Agreement: asset purchase
Counterparty: WFRSA and The Elizabeth Pritts Revocable Living Trust
Effective: 2023-03-16

Exact text from the filing

On March 16, 2023, Buyer entered into an Asset Purchase Agreement (the “APA”) with WFRSA and The Elizabeth Pritts Revocable Living Trust (the “Seller,” together with the WFRSA, the “Seller Parties”) pursuant to which Buyer agreed to acquire the Purchased Assets (as defined in the APA) related to WFRSA’s business.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Membership Interest Purchase Agreement with FLOW, IVF Science, LLC, and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust valued at $2,000,000 (effective 2023-03-16).

Action: entry
Agreement: equity purchase
Counterparty: FLOW, IVF Science, LLC, and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust
Value: $2,000,000
Effective: 2023-03-16

Exact text from the filing

On March 16, 2023, Buyer entered into a Membership Interest Purchase Agreement (the “MIPA”) with FLOW, IVF Science, LLC, a Wisconsin limited liability company (“IVF Science”), owned by Wael Megid, Ph.D. (“Dr. Megid”), and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust, a Trust created under the laws of the State of Wisconsin (each, a “Selling Member” and collectively, the “Selling Members”).

View on SEC.gov

268 material agreements filed in the last 30 days. Browse all material agreements →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-023175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.